All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| OPK / OPKO Health, Inc.
|
|
|
|
|
|
|
|
| COG / Cabot Oil & Gas Corp.
|
|
|
|
|
|
|
|
| YTEN / Yield10 Bioscience, Inc.
|
|
|
|
|
|
|
|
| 98235T107 / Wright Medical Group N.V.
|
|
|
|
|
|
|
|
| MDGN / Medgenics, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| PXD / Pioneer Natural Resources Company
|
|
|
|
|
|
|
|
| GNCA / Genocea Biosciences Inc
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| / Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| OMED / OptMed Inc
|
|
|
|
|
|
|
|
| CELGZ / Celgene Corporation Series A Contingent Value Rights
|
|
|
|
|
|
|
|
| AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
| PRTK / Paratek Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| SITOQ / SITO Mobile Ltd
|
|
|
|
|
|
|
|
| ROKA / Roka Bioscience, Inc.
|
|
|
|
|
|
|
|
| US46333XAD03 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1
|
|
|
|
|
|
|
|
| ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| WKHS / Workhorse Group Inc.
|
|
|
|
|
|
|
|
| ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ECA / EnCana Corp.
|
|
|
|
|
|
|
|
| MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
| CELG / Celgene Corp.
|
|
|
|
|
|
|
|
| PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| BIOL / BIOLASE, Inc.
|
|
|
|
|
|
|
|
| ARAY / Accuray Incorporated
|
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
| QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
| EQT / EQT Corporation
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
